CMS Pitches 2.4% Hospital Pay Bump, Mandatory Joint Replacement Model: 7 Things to Know

Why It Matters

The payment bump eases hospital revenue pressures while the mandatory joint‑replacement model pushes providers toward value‑based care, potentially reshaping Medicare spending patterns. Enhanced technology payments and stricter quality metrics aim to improve outcomes and align incentives across the health system.

Key Takeaways

• CMS proposes 2.4% Medicare hospital payment increase for FY2027.
• New mandatory CJR-X model expands joint replacement episodes nationwide.
• Additional payments for new technologies could rise $464 million in 2027.
• Hospital quality programs add sepsis readmission measure and new IQR metrics.

Pulse Analysis

The Centers for Medicare & Medicaid Services (CMS) unveiled its FY2027 Inpatient Prospective Payment System (IPPS) proposal, marking the first major payment adjustment since the 2025 rule. By applying a 3.2% market‑basket update and a 0.8‑point productivity offset, CMS aims to lift acute‑care and long‑term care hospital rates by 2.4%, translating to roughly $1.4 billion in additional Medicare dollars. Hospitals that meet updated quality reporting and electronic health‑record (EHR) standards will receive the full uplift, creating a clear incentive for data‑driven care management and compliance.

Perhaps the most consequential element is CJR‑X, the mandatory, nationwide expansion of the Comprehensive Care for Joint Replacement model. Beginning October 1, 2027, virtually all hospitals will be accountable for the total cost of hip, knee and ankle replacements, including the 90‑day post‑acute period. The original voluntary CJR program demonstrated measurable Medicare savings while preserving quality, and CMS expects the mandatory rollout to amplify those gains across a broader patient base. Providers will need to redesign care pathways, negotiate bundled contracts, and invest in coordinated post‑acute services to avoid payment penalties.

Beyond payment rates, the proposal reshapes several ancillary programs. CMS projects an extra $464 million for new‑technology add‑on payments, reflecting rapid adoption of advanced implants and robotics. The Hospital Inpatient Quality Reporting (IQR) program will add three new measures and revise mortality metrics, while the Hospital Readmissions Reduction Program introduces a sepsis readmission indicator in 2029. Finally, the rule extends nondiscrimination safeguards to graduate medical education and allied‑health training programs, reinforcing equity in the workforce. Collectively, these changes tighten the link between reimbursement, quality, and innovation, steering the U.S. hospital sector toward a more value‑centric future.